Bradley Thompson, a Member of the Firm in the Health Care and Life Sciences Practice in the Washington, DC office, was quoted in an article in Medical Device Daily on the likelihood that the FDA will regulate mobile phones used to transmit patients' medical data to doctors.
In the article, "FDA May Require PMAs For Cell Phones Transmitting ICD Data," Thompson noted that the market for cell phones that could serve as transmission devices for cardiac electrophysiology equipment is likely to feel the effect of a tougher regulatory process.
Thompson said the question of how to regulate the software in such a phone is "similar to what FDA faces with other ubiquitous software that is frequently used in medical applications," such as productivity software and operating systems.